FREE NEJM E-TOC    HOME   |   SUBSCRIBE   |   CURRENT ISSUE   |   PAST ISSUES   |   COLLECTIONS   |   Search Term  Advanced Search

Sign in | Get NEJM's E-Mail Table of Contents — Free | Subscribe

Previous Volume 342:564-571 February 24, 2000 Number 8 Next

	Since this article has no abstract, we have provided an extract of the first 100 words of the full text and any section headings.

	Full Text PDF Purchase this article Add to Personal Archive Add to Citation Manager Notify a Friend E-mail When Cited PubMed Citation

Each year in the United States, breast cancer is diagnosed in more than 170,000 women.¹ Despite this substantial burden of disease, however, assessment of breast-cancer risk has received very little attention outside the oncology clinic.^2,3 In primary care, the main result of the recognition of individual variation in breast-cancer risk is the use of age to determine recommendations regarding mammography (older age is a strong risk factor for breast cancer).⁴

Recent developments in the ability to predict and alter breast-cancer risk warrant a new look at the role of assessment of this risk in primary care. Physicians must become adept . . . [Full Text of this Article]

Why Evaluate Breast-Cancer Risk?

Decisions about Postmenopausal Hormone-Replacement Therapy

Decisions about the Use of Mammography for Women 40 to 49 Years of Age

Decisions about the Use of Tamoxifen for the Prevention of Breast Cancer

Decisions about Prophylactic Mastectomy

How to Evaluate Breast-Cancer Risk

Average Risk

Epidemiologic Risk Factors

Risk-Prediction Models

Genetic-Susceptibility Testing

Selecting a Prediction Method

Source Information

From the Department of Medicine (K.A., A.E., B.W.) and the Center for Clinical Epidemiology and Biostatistics (K.A.), University of Pennsylvania School of Medicine; the University of Pennsylvania Cancer Center (K.A., A.E., B.W.); and the Leonard Davis Institute of Health Economics, University of Pennsylvania (K.A.) — all in Philadelphia.

Address reprint requests to Dr. Armstrong at 1233 Blockley Hall, 423 Guardian Dr., Philadelphia, PA 19104-6021, or at karmstro@mail.med.upenn.edu.

References

This article has been cited by other articles:

• Guerra, C. E., Sherman, M., Armstrong, K. (2009). Diffusion of Breast Cancer Risk Assessment in Primary Care. J Am Board Fam Med 22: 272-279 [Abstract] [Full Text]  
• Hurria, A., Wong, F. L., Villaluna, D., Bhatia, S., Chung, C. T., Mortimer, J., Hurvitz, S., Naeim, A. (2008). Role of Age and Health in Treatment Recommendations for Older Adults With Breast Cancer: The Perspective of Oncologists and Primary Care Providers. JCO 26: 5386-5392 [Abstract] [Full Text]  
• Qaseem, A., Snow, V., Sherif, K., Aronson, M., Weiss, K. B., Owens, D. K., for the Clinical Efficacy Assessment Subcommittee, (2007). Screening Mammography for Women 40 to 49 Years of Age: A Clinical Practice Guideline from the American College of Physicians. ANN INTERN MED 146: 511-515 [Abstract] [Full Text]  
• Armstrong, K., Moye, E., Williams, S., Berlin, J. A., Reynolds, E. E. (2007). Screening Mammography in Women 40 to 49 Years of Age: A Systematic Review for the American College of Physicians. ANN INTERN MED 146: 516-526 [Abstract] [Full Text]  
• Dorval, M., Gauthier, G., Maunsell, E., Dugas, M. J., Rouleau, I., Chiquette, J., Plante, M., Laframboise, R., Gaudet, M., Bridge, P. J., INHERIT BRCAs, , Simard, J. (2005). No Evidence of False Reassurance among Women with an Inconclusive BRCA1/2 Genetic Test Result. Cancer Epidemiol. Biomarkers Prev. 14: 2862-2867 [Abstract] [Full Text]  
• Elmore, J. G., Gigerenzer, G. (2005). Benign Breast Disease -- The Risks of Communicating Risk. NEJM 353: 297-299 [Full Text]  
• Chlebowski, R. T., Chen, Z., Anderson, G. L., Rohan, T., Aragaki, A., Lane, D., Dolan, N. C., Paskett, E. D., McTiernan, A., Hubbell, F. A., Adams-Campbell, L. L., Prentice, R. (2005). Ethnicity and Breast Cancer: Factors Influencing Differences in Incidence and Outcome. JNCI J Natl Cancer Inst 97: 439-448 [Abstract] [Full Text]  
• Weiss, J. R., Moysich, K. B., Swede, H. (2005). Epidemiology of Male Breast Cancer. Cancer Epidemiol. Biomarkers Prev. 14: 20-26 [Abstract] [Full Text]  
• Cannistra, S. A. (2004). Cancer of the Ovary. NEJM 351: 2519-2529 [Full Text]  
• Sifri, R., Gangadharappa, S., Acheson, L. S. (2004). Identifying and Testing for Hereditary Susceptibility to Common Cancers. CA Cancer J Clin 54: 309-326 [Abstract] [Full Text]  
• Lewis, C. L., Kinsinger, L. S., Harris, R. P., Schwartz, R. J. (2004). Breast Cancer Risk in Primary Care: Implications for Chemoprevention. Arch Intern Med 164: 1897-1903 [Abstract] [Full Text]  
• Vacek, P. M., Geller, B. M. (2004). A Prospective Study of Breast Cancer Risk Using Routine Mammographic Breast Density Measurements. Cancer Epidemiol. Biomarkers Prev. 13: 715-722 [Abstract] [Full Text]  
• Contegiacomo, A., Pensabene, M., Capuano, I., Tauchmanova, L., Federico, M., Turchetti, D., Cortesi, L., Marchetti, P., Ricevuto, E., Cianci, G., Venuta, S., Barbieri, V., Silingardi, V. (2004). An oncologist-based model of cancer genetic counselling for hereditary breast and ovarian cancer. Ann Oncol 15: 726-732 [Abstract] [Full Text]  
• Tsao, A. S., Kim, E. S., Hong, W. K. (2004). Chemoprevention of Cancer. CA Cancer J Clin 54: 150-180 [Abstract] [Full Text]  
• Armstrong, K., Schwartz, J. S., Randall, T., Rubin, S. C., Weber, B. (2004). Hormone Replacement Therapy and Life Expectancy After Prophylactic Oophorectomy in Women With BRCA1/2 Mutations: A Decision Analysis. JCO 22: 1045-1054 [Abstract] [Full Text]  
• Verkooijen, H. M., Fioretta, G., Chappuis, P. O., Vlastos, G., Sappino, A. P., Benhamou, S., Bouchardy, C. (2004). Set-up of a population-based familial breast cancer registry in Geneva, Switzerland: validation of first results. Ann Oncol 15: 350-353 [Abstract] [Full Text]  
• Hampel, H, Sweet, K, Westman, J A, Offit, K, Eng, C (2004). Referral for cancer genetics consultation: a review and compilation of risk assessment criteria. J. Med. Genet. 41: 81-91 [Abstract] [Full Text]  
• Halls, S. B., Crystal, P., Karakis, I., Strano, S., Koretz, M. (2004). Statistical Comparison of Proportions. Am. J. Roentgenol. 182 : 259-260 [Full Text]  
• Morris, E. A., Liberman, L., Ballon, D. J., Robson, M., Abramson, A. F., Heerdt, A., Dershaw, D. D. (2003). MRI of Occult Breast Carcinoma in a High-Risk Population. Am. J. Roentgenol. 181: 619-626 [Abstract] [Full Text]  
• Liberman, L., Morris, E. A., Dershaw, D. D., Abramson, A. F., Tan, L. K. (2003). Ductal Enhancement on MR Imaging of the Breast. Am. J. Roentgenol. 181: 519-525 [Abstract] [Full Text]  
• Dalpe, R., Bouchard, L., Houle, A.-J., Bedard, L. (2003). Watching the Race to Find the Breast Cancer Genes. Science Technology Human Values 28: 187-216 [Abstract]  
• Bach, P. B., Kattan, M. W., Thornquist, M. D., Kris, M. G., Tate, R. C., Barnett, M. J., Hsieh, L. J., Begg, C. B. (2003). Variations in Lung Cancer Risk Among Smokers. JNCI J Natl Cancer Inst 95: 470-478 [Abstract] [Full Text]  
• Pichert, G., Bolliger, B., Buser, K., Pagani, O. (2003). Evidence-based management options for women at increased breast/ovarian cancer risk. Ann Oncol 14: 9-19 [Abstract] [Full Text]  
• Mann, R. J., Keri, R. A., Nilson, J. H. (2003). Consequences of Elevated Luteinizing Hormone on Diverse Physiological Systems: Use of the LH{beta}CTP Transgenic Mouse as a Model of Ovarian Hyperstimulation-induced Pathophysiology. Recent Prog Horm Res 58: 343-375 [Abstract] [Full Text]  
• Chandawarkar, R. Y., Guyton, D. P. (2002). Oncologic Mathematics: Evolution of a New Specialty. Arch Surg 137: 1428-1434 [Abstract] [Full Text]  
• Guttmacher, A. E., Collins, F. S. (2002). Genomic Medicine -- A Primer. NEJM 347: 1512-1520 [Full Text]  
• Milliken, E. L., Ameduri, R. K., Landis, M. D., Behrooz, A., Abdul-Karim, F. W., Keri, R. A. (2002). Ovarian Hyperstimulation by LH Leads to Mammary Gland Hyperplasia and Cancer Predisposition in Transgenic Mice. Endocrinology 143: 3671-3680 [Abstract] [Full Text]  
• Sinclair, A. (2002). Genetics 101: detecting mutations in human genes. CMAJ 167: 275-279 [Full Text]  
• Chlebowski, R. T., Col, N., Winer, E. P., Collyar, D. E., Cummings, S. R., Vogel, V. G. III, Burstein, H. J., Eisen, A., Lipkus, I., Pfister, D. G. (2002). American Society of Clinical Oncology Technology Assessment of Pharmacologic Interventions for Breast Cancer Risk Reduction Including Tamoxifen, Raloxifene, and Aromatase Inhibition. JCO 20: 3328-3343 [Abstract] [Full Text]  
• Kinsinger, L. S., Harris, R., Woolf, S. H., Sox, H. C., Lohr, K. N. (2002). Chemoprevention of Breast Cancer: A Summary of the Evidence for the U.S. Preventive Services Task Force. ANN INTERN MED 137: 59-69 [Abstract] [Full Text]  
• Thomas, D. B., Carter, R. A., Bush, W. H. Jr., Ray, R. M., Stanford, J. L., Lehman, C. D., Daling, J. R., Malone, K., Davis, S. (2002). Risk of Subsequent Breast Cancer in Relation to Characteristics of Screening Mammograms from Women Less Than 50 Years of Age. Cancer Epidemiol. Biomarkers Prev. 11: 565-571 [Abstract] [Full Text]  
• Love, R. R. (2002). Breast Cancer Prevention. The Oncologist 7: 100-102 [Full Text]  
• Powell, B. L., van Staveren, I. L., Roosken, P., Grieu, F., Berns, E. M.J.J., Iacopetta, B. (2002). Associations between common polymorphisms in TP53 and p21WAF1/Cip1 and phenotypic features of breast cancer. Carcinogenesis 23: 311-315 [Abstract] [Full Text]  
• Stoutjesdijk, M. J., Boetes, C., Jager, G. J., Beex, L., Bult, P., Hendriks, J. H. C. L., Laheij, R. J. F., Massuger, L., van Die, L. E., Wobbes, T., Barentsz, J. O. (2001). Magnetic Resonance Imaging and Mammography in Women With a Hereditary Risk of Breast Cancer. JNCI J Natl Cancer Inst 93: 1095-1102 [Abstract] [Full Text]  
• Bastian, L. A., Lipkus, I. M., Kuchibhatla, M. N., Weng, H. H., Halabi, S., Ryan, P. D., Skinner, C. S., Rimer, B. K. (2001). Women's Interest in Chemoprevention for Breast Cancer. Arch Intern Med 161: 1639-1644 [Abstract] [Full Text]  
• Ziv, E., Cauley, J., Morin, P. A., Saiz, R., Browner, W. S. (2001). Association Between the T29->C Polymorphism in the Transforming Growth Factor {beta}1 Gene and Breast Cancer Among Elderly White Women: The Study of Osteoporotic Fractures. JAMA 285: 2859-2863 [Abstract] [Full Text]  
• Levine, M., Moutquin, J.-M., Walton, R., Feightner, J. (2001). Chemoprevention of breast cancer: A joint guideline from the Canadian Task Force on Preventive Health Care and the Canadian Breast Cancer Initiative's Steering Committee on Clinical Practice Guidelines for the Care and Treatment of Breast Cancer. CMAJ 164: 1681-1690 [Abstract] [Full Text]  
• McTiernan, A., Kuniyuki, A., Yasui, Y., Bowen, D., Burke, W., Culver, J. B., Anderson, R., Durfy, S. (2001). Comparisons of Two Breast Cancer Risk Estimates in Women with a Family History of Breast Cancer. Cancer Epidemiol. Biomarkers Prev. 10: 333-338 [Abstract] [Full Text]  
• Burstein, H. J., Winer, E. P. (2000). Primary Care for Survivors of Breast Cancer. NEJM 343: 1086-1094 [Full Text]  
• Chlebowski, R. T. (2000). Reducing the Risk of Breast Cancer. NEJM 343: 191-198 [Full Text]